Patients with diabetes could benefit from cell-based insulin therapy, but the supply of human islet tissue is limited. A study now reports an approach in which human-pluripotent-stem-cell-derived islet β-cells are purified and re-aggregated to generate cells that more closely resemble mature human β-cells.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Global report on diabetes WHO 2016. https://www.who.int/diabetes/global-report/en/
DiMeglio, L. A., Evans-Molina, C. & Oram, R. A. Lancet 391, 2449–2462 (2018).
Muoio, D. M. & Newgard, C. B. Nat. Rev. Mol. Cell Biol. 9, 193–205 (2008).
Shapiro, A. M., Pokrywczynska, M. & Ricordi, C. Nat. Rev. Endocrinol. 13, 268–277 (2017).
Nair, G. G. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-018-0271-4 (2019).
Pagliuca, F. W. et al. Cell 159, 428–439 (2014).
Rezania, A. et al. Nat. Biotech. 32, 1121–1133 (2014).
Russ, H. A. et al. EMBO J. 34, 1759–1772 (2015).
Henquin, J.-C., Dufrane, D., Kerr-Conte, J. & Nequin, M. Am. J. Physiol Endocrin. Metab. 309, 640–650 (2015).
Newgard, C. B. Cell Metab. 25, 43–56 (2017).
Prentki, M., Matschinsky, F. M. & Madiraju, S. R. Cell Metab. 18, 162–185 (2013).
Yoshihara, E. et al. Cell Metab. 23, 622–634 (2016).
Henquin, J.-C. Diabetes Res. Clin. Pract. 93, S27–S31 (2011).
Ferdaoussi, M. et al. J. Clin. Invest. 125, 3847–3860 (2015).
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Hohmeier, H.E., An, J. & Newgard, C.B. Improving human β-cell maturation in vitro. Nat Cell Biol 21, 119–121 (2019). https://doi.org/10.1038/s41556-019-0277-6